SEC Form 4 · accession 0001062993-18-001263
BIOSPECIFICS TECHNOLOGIES CORP · BSTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jennifer M Chao
Director
Period of report
Mar 15, 2018
Accepted (ET)
Mar 19, 2018 · 6:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875622
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $41.82 | Mar 15, 2018 | A | 15,000 | A | — | Mar 15, 2028 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The options were granted on March 15, 2018, and will vest in four equal annual installments beginning on the first anniversary of the grant date.